NEW YORK (GenomeWeb) – SeraCare Life Sciences said this week that it has partnered with Navican and Royal Philips on the integration of SeraCare's clinical NGS QC solution to support the roll out of Navican's TheraMap Precision Cancer Care services. The integrated solution merges SeraCare's iQ NGS QC Management software and Philips' IntelliSpace Genomics Platform to automate tracking of all critical genomics workflow QC parameters necessary for monitoring, trending, and reporting on the performance of the TheraMap clinical NGS assay.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.